SCHEMBL6521808

SCHEMBL6521808

CCOc1cc2c(C(=O)O)c(CBr)n(C)c2cc1Br

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.53
MEN1 O00255 3/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
ALDH1A1 P00352 4/20 0.49
TSHR P16473 3/20 0.46
SPR P35270 1/20 0.45
MAPT P10636 2/20 0.45
P4HB P07237 1/20 0.45
HTT P42858 1/20 0.44
PKM P14618 1/20 0.43
GPR55 Q9Y2T6 1/20 0.43
HSD17B10 Q99714 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.41
KDM4E B2RXH2 1/20 0.41
POLB P06746 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
SAE1 Q9UBE0 1/20 0.41
UBA2 Q9UBT2 1/20 0.41
LMNA P02545 2/20 0.40
SMPD1 P17405 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2852930 0.88 ALDH1A1 (0.62) KMT2AMEN1L3MBTL1ALDH1A1TSHR
SCHEMBL28442067 0.85 KMT2A (0.53) KMT2AMEN1L3MBTL1ALDH1A1TSHR
SCHEMBL2877355 0.78 ALDH1A1 (0.76) KMT2AMEN1L3MBTL1ALDH1A1TSHR
SCHEMBL9585968 0.76 KMT2A (0.70) KMT2AMEN1ALDH1A1TSHRMAPT
SCHEMBL14621743 0.76 ALDH1A1 (0.59) KMT2AMEN1L3MBTL1ALDH1A1TSHR
SCHEMBL25947449 0.73 ALDH1A1 (0.69) KMT2AMEN1L3MBTL1ALDH1A1TSHR
SCHEMBL6524004 0.73 KMT2A (0.60) KMT2AMEN1L3MBTL1ALDH1A1TSHR
SCHEMBL25947070 0.72 TSHR (0.58) KMT2AALDH1A1TSHRSPRMAPT
SCHEMBL25946421 0.72 ALDH1A1 (0.54) KMT2AMEN1ALDH1A1TSHRMAPT
Ether SCHEMBL2857743 0.72 KMT2A (0.70) KMT2AMEN1L3MBTL1ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065919-A1 5-Substituted Indol-3-Carboxylic Acid Derivatives Exhibiting Antiviral Activity a Method for the Production and Use Thereof OOO "BINATEKH" (RU) 2011-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065919-A1 5-Substituted Indol-3-Carboxylic Acid Derivatives Exhibiting Antiviral Activity a Method for the Production and Use Thereof CBR3, IFNAR1, SIGMAR1 KMT2A 4466/4885MEN1 4185/4885L3MBTL1 1429/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.